Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    20580422 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Exenatide once weekly (BYDUREON™)
2 Completed
Has Results
A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide once weekly;   Drug: sitagliptin;   Drug: pioglitazone;   Drug: placebo tablet;   Drug: placebo once weekly

Study has passed its completion date and status has not been verified in more than two years.